[DOI] [PubMed] [Google Scholar] 21.Allen J
The present invention also relates to a pharmaceutical or diagnostic composition according to the above, which in addition to one or more of the BPC peptide salts of the present invention, contains trehalose, in particular for peroral use, and/or pharmaceutically or diagnostically acceptable carriers, dilutents and/or additives
Local controlled release of corticosteroids extends surgically induced joint instability by inhibiting tissue healing
Much of the human signal that circulates online comes from small studies, uncontrolled observations, or products that combine a copper peptide with other actives minoxidil, botanical extracts, procedural microneedling, or growth-factor cocktails
BPC-157 was administered at doses of 10 g/kg, 1 g/kg, 100 ng/kg, and 10 ng/kg throughout the experiment, starting on day zero when therapy began, and daily during the trial periods of 7, 14, 21, 28, and 42 days